Back to Report Store Home

Dermatological Burns, Scars and Ulcers Drug Development Pipeline Review, 2018

  • Published: Sep-2018
  • Report Code: GBIHC046IDB
  • Report Format: pdf

Description

List of Tables

Table 1: Number of Products under Development for Pressure Ulcers

Table 2: Number of Products under Development by Companies, Pressure Ulcers

Table 3: Products under Development by Companies, Pressure Ulcers

Table 4: Number of Products under Development for Venous Leg Ulcers (Crural Ulcer)

Table 5: Number of Products under Development by Companies, Venous Leg Ulcers (Crural Ulcer)

Table 6: Products under Development by Companies, Venous Leg Ulcers (Crural Ulcer)

Table 7: Number of Products under Development for Burns

Table 8: Number of Products under Development by Companies, Burns

Table 9: Number of Products under Development by Universities/Institutes, Burns

Table 10: Products under Development by Companies, Burns

Table 11: Products under Development by Universities/Institutes, Burns

Table 12: Number of Products under Development for Scar

Table 13: Number of Products under Development by Companies, Scar

Table 14: Number of Products under Development by Universities/Institutes, Scar

Table 15: Products under Development by Companies, Scar

Table 16: Products under Development by Universities/Institutes, Scar

Table 17: Number of Products by Stage and Target, Pressure Ulcers

Table 18: Number of Products by Stage and Mechanism of Action, Pressure Ulcers

Table 19: Number of Products by Stage and Route of Administration, Pressure Ulcers

Table 20: Number of Products by Stage and Molecule Type, Pressure Ulcers

Table 21: Number of Products by Stage and Target, Venous Leg Ulcers (Crural Ulcer)

Table 22: Number of Products by Stage and Mechanism of Action, Venous Leg Ulcers (Crural Ulcer)

Table 23: Number of Products by Stage and Route of Administration, Venous Leg Ulcers (Crural Ulcer)

Table 24: Number of Products by Stage and Molecule Type, Venous Leg Ulcers (Crural Ulcer)

Table 25: Number of Products by Stage and Target, Burns

Table 26: Number of Products by Stage and Mechanism of Action, Burns

Table 27: Number of Products by Stage and Route of Administration, Burns

Table 28: Number of Products by Stage and Molecule Type, Burns

Table 29: Number of Products by Stage and Target, Scar

Table 30: Number of Products by Stage and Mechanism of Action, Scar

Table 31: Number of Products by Stage and Route of Administration, Scar

Table 32: Number of Products by Stage and Molecule Type, Scar

Table 33: Pressure Ulcers – Pipeline by EyeGene Inc

Table 34: Pressure Ulcers – Pipeline by Izun Pharmaceuticals Corp

Table 35: Pressure Ulcers – Pipeline by MimeTech Srl

Table 36: Pressure Ulcers – Pipeline by NovaLead Pharma Pvt Ltd

Table 37: Venous Leg Ulcers (Crural Ulcer) – Pipeline by CardioVascular BioTherapeutics Inc

Table 38: Venous Leg Ulcers (Crural Ulcer) – Pipeline by CytoTools AG

Table 39: Venous Leg Ulcers (Crural Ulcer) – Pipeline by Daval International Ltd

Table 40: Venous Leg Ulcers (Crural Ulcer) – Pipeline by Factor Therapeutics Ltd

Table 41: Venous Leg Ulcers (Crural Ulcer) – Pipeline by FirstString Research Inc

Table 42: Venous Leg Ulcers (Crural Ulcer) – Pipeline by GangaGen Inc

Table 43: Venous Leg Ulcers (Crural Ulcer) – Pipeline by MallInckrodt Plc

Table 44: Venous Leg Ulcers (Crural Ulcer) – Pipeline by MediWound Ltd

Table 45: Venous Leg Ulcers (Crural Ulcer) – Pipeline by NovaLead Pharma Pvt Ltd

Table 46: Venous Leg Ulcers (Crural Ulcer) – Pipeline by Promore Pharma AB

Table 47: Burns – Pipeline by AlgiPharma AS

Table 48: Burns – Pipeline by Alliance Pharma Plc

Table 49: Burns – Pipeline by Amarantus Bioscience Holdings Inc

Table 50: Burns – Pipeline by CFM Pharma Holding BV

Table 51: Burns – Pipeline by Destiny Pharma Plc

Table 52: Burns – Pipeline by Energenesis Biomedical Co Ltd

Table 53: Burns – Pipeline by Madam Therapeutics BV

Table 54: Burns – Pipeline by MallInckrodt Plc

Table 55: Burns – Pipeline by MediWound Ltd

Table 56: Burns – Pipeline by Phagelux Inc

Table 57: Burns – Pipeline by Se-cure Pharmaceuticals Ltd

Table 58: Burns – Pipeline by Therapure Biopharma Inc

Table 59: Burns – Pipeline by USV Pvt Ltd

Table 60: Scar – Pipeline by Abzena Plc

Table 61: Scar – Pipeline by Altacor Ltd

Table 62: Scar – Pipeline by BirchBioMed Inc

Table 63: Scar – Pipeline by Cotinga Pharmaceuticals Inc

Table 64: Scar – Pipeline by Kringle Pharma Inc

Table 65: Scar – Pipeline by Moerae Matrix Inc

Table 66: Scar – Pipeline by Pharmaxis Ltd

Table 67: Scar – Pipeline by Promore Pharma AB

Table 68: Scar – Pipeline by Resolys Bio Inc

Table 69: Scar – Pipeline by RXi Pharmaceuticals Corp

Table 70: Scar – Pipeline by Synedgen Inc

Table 71: Scar – Pipeline by Vascular BioSciences

Table 72: Pressure Ulcers – Dormant Projects

Table 73: Venous Leg Ulcers (Crural Ulcer) – Dormant Projects

Table 74: Burns – Dormant Projects

Table 75: Scar – Dormant Projects

Table 76: Pressure Ulcers – Discontinued Products

Table 77: Venous Leg Ulcers (Crural Ulcer) – Discontinued Products

Table 78: Burns – Discontinued Products

Table 79: Scar – Discontinued Products

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards